James F. Zawada, Ph.D.
Affiliations: | 2004 | Stanford University, Palo Alto, CA |
Area:
Chemical EngineeringGoogle:
"James Zawada"Parents
Sign in to add mentor| James R. Swartz | grad student | 2004 | Stanford | |
| (Scale-up, optimization, and analysis of Escherichia coli extracts for cell -free protein synthesis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hanson J, Groff D, Carlos A, et al. (2023) An Integrated In Vivo/In Vitro Protein Production Platform for Site-Specific Antibody Drug Conjugates. Bioengineering (Basel, Switzerland). 10 |
| Zawada JF, Burgenson D, Yin G, et al. (2022) Cell-free technologies for biopharmaceutical research and production. Current Opinion in Biotechnology. 76: 102719 |
| Abrahams C, Krimm S, Li X, et al. (2019) Abstract NT-090: PRECLINICAL ACTIVITY AND SAFETY OF STRO-002, A NOVEL ADC TARGETING FOLATE RECEPTOR ALPHA FOR OVARIAN AND ENDOMETRIAL CANCER Clinical Cancer Research. 25 |
| Solis W, Almeida VD, Yu A, et al. (2018) Abstract 742: Nonclinical safety evaluation of STRO-001, a site-specific anti-CD74 antibody-drug conjugate for the potential treatment of B-cell malignancies Cancer Research. 78: 742-742 |
| Li X, Abrahams C, Zhou S, et al. (2018) Abstract 1782: Discovery and activity of STRO-002, a novel ADC targeting folate receptor alpha for ovarian and endometrial cancer Cancer Research. 78: 1782-1782 |
| Abrahams C, Li X, DeAlmeida V, et al. (2017) Abstract 67: Characterization and preclinical development of STRO-001, a novel CD74-targeting antibody-drug conjugate (ADC) for the treatment of B-cell malignancies Cancer Research. 77: 67-67 |
| Li X, Abrahams C, Embry M, et al. (2016) Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin's Lymphoma (NHL) Blood. 128: 464-464 |
| Abrahams C, Li X, Yu A, et al. (2016) Discovery and Preclinical Development of Novel CD74-Targeting Antibody-Drug Conjugates (ADCs) with Significant Activity in Multiple Myeloma (MM) Cell Lines and Xenograft Models Blood. 128: 4465-4465 |
| Cai Q, Hanson JA, Steiner AR, et al. (2015) A simplified and robust protocol for immunoglobulin expression in Escherichia coli cell-free protein synthesis systems. Biotechnology Progress. 31: 823-31 |
| Yin G, Garces ED, Yang J, et al. (2012) Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system. Mabs. 4: 217-25 |